NEW YORK (AP) — U.S. stocks jumped to record highs Friday after a strong jobs report for the month of July gave investors more confidence that the economy is still growing. Financial and technology stocks soared and investors sold the safe assets they have favored for most of this year.
The Labor Department said U.S. employers added 255,000 jobs in July, far more than investors expected and the second straight month of strong gains after shaky reports this spring. Stocks made their biggest gain in almost a month. Banks traded higher as investors anticipated higher interest rates and bigger profits on mortgages and other loans. The Nasdaq composite closed at a record high as tech stocks continued to climb. Consumer companies also made big gains. Investors sold bonds, precious metals, and phone and utility companies, safe investments that soared earlier this year as investors worried about the health of the economy.
“It looks like the economy is improving, it looks like corporate earnings are on the upswing,” said Sam Stovall, U.S. equity strategist for S&P Capital IQ. That marks a change from earlier this year, he said, when investors worried the U.S. would fall into a recession and tech companies would suffer as businesses cut spending. But tech stocks have come back to lead the market higher over the last few months.
The Dow Jones industrial average rose 191.48 points, or 1 percent, to 18,543.53. The Standard & Poor’s 500 index climbed 18.62 points, or 0.9 percent, to 2,182.87. The Nasdaq advanced 54.87 points, or 1.1 percent, to 5,221.12.
Most Read Business Stories
- Why did it take more than 2 months to stop the largest fraud in Washington state history?
- REI to sell its new Bellevue headquarters and shift office work to multiple Seattle-area sites
- Boeing deliveries slow to a trickle, while 737 MAX cancellations grow
- Seattle-based cookware chain Sur La Table sells for around $90 million
- Apple’s stock split should put a focus on numbers that truly matter
The strong jobs report suggests that Britain’s vote to leave the European Union in late June didn’t have much effect on hiring plans for U.S. companies. The unemployment rate remained at 4.9 percent and hourly pay continued to rise. The hiring spree follows an even larger surge in June and represents a turnaround from weak job growth in the first half of this year, including disappointing job gains in April and May.
Banks rose the most, as higher interest rates boost their profits on lending. Bank of America rose 57 cents, or 3.9 percent, to $15.05 and Citigroup added $1.88, or 4.3 percent, to $45.72.
Kate Warne, an investment strategist for Edward Jones, said the report reassured investors but won’t vanquish their fears entirely.
“With an election where both candidates are likely to talk about how badly the economy is doing and how disappointing growth has been, investors as a whole are more anxious than the job picture would suggest,” she said.
The Federal Reserve has been saying for months that it intends to raise interest rates if the economy’s strength warrants it. July’s report provides more evidence the economy is doing well, boosting the chances that interest rates will go up. But Warne said investor views on the economy and the Fed will keep fluctuating.
“When the Fed indicates that they’re data dependent, that means investors are going to be data dependent as well,” she said.
Bond prices fell and the yield on the 10-year U.S. Treasury note jumped to 1.59 percent from 1.50 percent.
Kraft Heinz, the company behind Oscar Mayer bologna, Jell-O pudding and Velveeta cheese, also traded higher after it reported a larger profit than analysts expected. Its stock picked up $3.25, or 3.8 percent, to $88.79.
After Bristol-Myers Squibb said one of its cancer drugs failed in a clinical trial, its stock suffered its biggest slump since 2000. Meanwhile rival drugmaker Merck soared by the most in seven years. Bristol-Myers sank $12.04, or 16 percent, to $63.28 after saying its drug Opdivo did not halt progression of non-small cell lung cancer in the study.
Merck makes a drug called Keytruda that also stimulates patients’ immune systems to fight lung cancer. The company, which took in $533 million from Keytruda this year, rose $6.02, or 10.4 percent, to $63.86. Merck was the largest gainer among S&P 500 stocks, and Bristol-Myers Squibb took the largest loss.
Security software maker FireEye tumbled after it reported weak sales, cut its forecasts and announced job cuts. Its stock plunged $2.02, or 12.1 percent, to $14.73. Rival software firm Symantec disclosed a larger profit and better sales than expected in its fiscal first quarter, and its full-year profit forecast was stronger than expected. Its stock climbed 86 cents, or 4.1 percent, to $21.89.
Benchmark U.S. crude slid 13 cents to $41.80 per barrel in New York while Brent crude, used to price international oils, dipped 2 cents to $44.27 a barrel in London.
The price of gold fell $23, or 1.7 percent, to $1,344.40 an ounce, its biggest loss since May. Silver fell 63 cents, or 3.1 percent, to $19.82 an ounce. Copper lost 2 cents to $2.15 a pound.
In other energy trading, wholesale gasoline held steady at $1.38 a gallon. Heating oil lost 1 cent to $1.32 a gallon. Natural gas fell 6 cents to $2.77 per 1,000 cubic feet.
The dollar rose to 101.75 yen from 101.17 yen and the euro fell to $1.1091 from $1.1127.
European stocks also advanced. France’s CAC-40 rose 1.5 percent and the DAX in Germany advanced 1.4 percent. London’s FTSE 100 was 0.8 percent higher. The Shanghai Composite Index shed 0.2 percent and Tokyo’s Nikkei 225 was little changed. In South Korea, the Kospi rose 0.9 percent.
AP Markets Writer Marley Jay can be reached at http://twitter.com/MarleyJayAP . His work can be found at http://bigstory.ap.org/journalist/marley-jay